Source: Virtual Congress 2021 – Advances in diagnosis, treatment and clinical management of nontuberculous mycobacterial disease



Rating:

Share or cite this content

Citations should be made in the following way:
P. Marty (Rochester, United States of America), P. Escalante (Rochester, United States of America), V. Van Keulen (Rochester, United States of America), C. Erskine (Rochester, United States of America), M. Shah (Rochester, United States of America), K. Pennington (Rochester, United States of America), T. Peikert (Rochester, United States of America). Immune profiling to differentiate progressive from non-progressive non-tuberculous mycobacteria lung disease: A pilot study. 3088

Member's Comments

No comment yet.

Related content which might interest you: Long-term follow-up study of patients with pneumoconiosis complicated by nontuberculous mycobacterial lung disease: report of four cases Source: Eur Respir J 2001; 18: Suppl. 33, 443s Year: 2001 Nontuberculous mycobacterial pulmonary disease in anorexic patients with severe malnutrition: a retrospective study Source: Eur Respir J 2004; 24: Suppl. 48, 197s Year: 2004 When is an infectious disease? The clinical spectrum of nontuberculous mycobacterial pulmonary disease Source: International Congress 2019 – New guidelines for treatment of nontuberculous mycobacterial pulmonary disease Year: 2019 Pulmonary non-tuberculous mycobacterial infection in patients without predisposing condition, morphological and immunological overview of a french cohort Source: Virtual Congress 2021 – Advances in the diagnosis of tuberculosis, multidrug-resistant tuberculosis and nontuberculous mycobacterial disease Year: 2021 Clinical relevance of Mycobacterium simiae in pulmonary samples Source: Eur Respir J 2008; 31: 106-109 Year: 2008 Clinical outcome of multiple nontuberculous mycobacteria infection among people with bronchiectasis in Taiwan: a cohort study Source: Virtual Congress 2020 – New investigations of bronchiectasis and non-tuberculous mycobacteria Year: 2020 Treatment outcomes of non tuberculous mycobacterial (NTM) pulmonary disease. Multicenter study Source: Virtual Congress 2020 – Non-tuberculous mycobacteria and latent tuberculosis infection Year: 2020 Management of pulmonary nontuberculous mycobacteria disease Source: Eur Respir Monogr 2018; 81: 222-237 Year: 2018 Preliminary validation of the NTM Module: a patient-reported outcome measure for patients with pulmonary nontuberculous mycobacterial disease Source: Eur Respir J, 55 (1) 1901300; 10.1183/13993003.01300-2019 Year: 2020 Comparative study of clinical features between elderly and non-elderly patients with pulmonary nontuberculous mycobacterial disease Source: Virtual Congress 2021 – Epidemiological aspects of tuberculosis Year: 2021 Non-tuberculous mycobacterial lung disease and COPD Source: Eur Respir Monogr 2015; 69: 172-184 Year: 2015 Diagnosis, classification and epidemiology of pulmonary nontuberculous mycobacterial disease Source: Eur Respir Monogr 2018; 81: 204-221 Year: 2018 Evaluating the use of the interferon-γ response to mycobacterium tuberculosis (MTB) specific antigens to diagnose latent tuberculosis infection in patients with chronic inflammatory joint and skin diseases Source: Annual Congress 2011 - Tuberculin skin tests, interferon-gamma release assays and beyond Year: 2011 Cases series on nontuberculous mycobacterial (NTM) lung disease and silicosis in Brazil Source: International Congress 2017 – Case reports and series Year: 2017 The impact of new ATS/IDSA guideline for nontuberculous mycobacterial disease on the diagnosis of nontuberculous mycobacterial lung disease in Korea Source: Annual Congress 2008 - Aetiology of respiratory infections: mycobacteria and fungi Year: 2008 Outcomes of patients undergoing treatment for non-tuberculous mycobacteria lung disease Source: International Congress 2019 – Clinical investigations of non-TB mycobacterial infection Year: 2019 Evaluation of the airway microbiome in nontuberculous mycobacteria disease Source: Eur Respir J, 52 (4) 1800810; 10.1183/13993003.00810-2018 Year: 2018 Susceptibility to nontuberculous mycobacterial lung disease Source: Eur Respir J 2008; 31: 1322-1333 Year: 2008 Clinical and immunological characteristics of patients with pulmonary Mycobacterium abscessus disease without cystic fibrosis Source: International Congress 2019 – Clinical and translational studies of bronchiectasis and non-TB mycobacterial infection Year: 2019 Silica exposure, silicosis, autoimmune diseases, tuberculosis and nontuberculous pulmonary mycobacterial disease Source: International Congress 2016 – Occupational epidemiology Year: 2016